AstraZeneca chief investigator backs India’s covishield dose plan
The chief investigator of the AstraZeneca vaccine clinical trials, Professor Andrew Pollard has backed the 12-16 week gap between the…
The chief investigator of the AstraZeneca vaccine clinical trials, Professor Andrew Pollard has backed the 12-16 week gap between the…
Dr. VK Paul, member (Health) of NITI Aayog who supervises India’s task force in the pandemic affirmed that the initial…
To put the state’s COVID-19 death count in the public domain was a reluctance of the Bihar government which was…
On Thursday, Fortis Healthcare declared that Sputnik V COVID 19 vaccine will be available at two of its hospitals from…
According to a Reuters analysis, India and Brazil report most deaths each day on a seven-day average, and are still…
Covaxin has inched a step closer to WHO emergency use listing. The pre-submission meeting with WHO is now planned for…
The comment in 'The Lancet' journal was authored by as many as 21 authors, including Biocon chief Kiran Mazumdar-Shaw.
On Friday, the Customised Crash course programme for COVID-19 frontline workers at 11:00 a.m. will be launched by Prime Minister…
The US CDC has classified the Delta, a highly transmissible COVID-19 variant, as a 'variant of concern'.
Pune-based vaccine maker Serum Institute of India (SII) is expected to begin clinical trials for the Novavax Covid vaccine for…
Black Fungus infection needs to be caught as early as possible because it is aggressive and dead tissue has to…
As people are now fleeting to get vaccines, there is a severe shortage of COVID-19 vaccines. Other than mass production…